FEBRUARY 2023LIFE SCIENCES REVIEW 19As a privately-held global company with over two decades of industry experience, CAR T Global Consultant Inc. assists cell therapy firms in commercializing CAR T cell therapy assets. CAR T Global Consultant Inc. offers cell therapy specific expertise in four primary divisions including Executive planning, Commercialization, Medical Affairs and Clinical Operations. The company rapidly established itself as the go-to strategic partner in the USA, Canada and Europe. They are planning the expansion phase in the Asian market in 2023. "We are well-versed with every nuance within the cell and gene therapy markets. We can fulfill the needs of small biotech companies that want to strengthen and secure their commercialization pathways and bigger pharmaceutical companies with current marketed assets that demand product differentiation, best-of-class execution, and KOLs engagement. Depending on our clients' specific demands, we build consultant teams tailored to their projects from our diverse network of talented industry leaders with specific cell therapy expertise," states Köszegi. The All-inclusive Cell and Gene Therapy Consultant PartnerCAR T Global Consultant Inc. set up shop to take cell and gene therapy assets of clients from ideation to commercialization and make it a reality for patients. It can help navigate the complex and multi-faceted process of a successful product launch by assisting them from the early stages of the cell therapy development path to pre-launch, identifying a suitable plan and the therapeutic product profile. CAR T Global Consultant Inc. specializes in supporting clients with market assessments, marketing plans, and pricing strategies related to commercialization. They support clients in leveraging the right strategies throughout the different lifecycle phases and guiding cell therapy companies with assets in development, assets less than three years from approval, and marketed assets.To do so, CAR T Global Consultant Inc. specializes in four core service areas--commercialization services, executive global planning, medical affairs, and clinical operations services.Commercialization servicesOn the commercial services side, CAR T Global Consultant Inc. has four main offerings: strategic portfolio assessment, CAR T landscape analysis and competitive intelligence, commercialization readiness, and marketing strategy and brand differentiation.As part of strategic portfolio assessments, CAR T Global Consultant Inc. conducts assessments to validate market size based on epidemiology figures and forecasts. These are founded on the prioritization of markets over selected years to create optimal prediction and profitability models based on current and future cost of goods (COGS) estimations. The company's landscape analysis and competitive intelligence service helps benchmark with other cell and gene products in the market and The field of cell and gene therapy is evolving quickly; to create a successful commercial pathway, we need to build from past experiences and predict future implications. That's where we come in
< Page 9 | Page 11 >